Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Stereotactic radiation therapy for oligmetastases

Dr David Palma – London Health Sciences Centre, London, Canada
Stereotactic radiation therapy for oligmetastases ( Dr David Palma – London Health Sciences Centre, London, Canada )
23 Oct 2015

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel
What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )
6 Oct 2015

Mantle cell lymphoma current treatment practices

Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby
Mantle cell lymphoma current treatment practices ( Prof Georg Hess, Prof Christian Buske, Prof Steven Le Gouill, Prof Eva Kimby )
2 Oct 2015

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015

ecancermedicalscience editor's choice for August 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for August 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
27 Aug 2015

De-activating chromosomes to prevent cancer

Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy
De-activating chromosomes to prevent cancer ( Dr Philip Avner - Head of EMBL Monterotondo, Milan, Italy )
21 Jul 2015

From stem cell to cancer stem cell

Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy
From stem cell to cancer stem cell ( Prof Paolo Di Fiore - IFOM-IEO, Milan, Italy )
21 Jul 2015

New emerging treatments in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro
New emerging treatments in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Heinz Ludwig, Prof Philippe Moreau, Prof Mario Boccadoro )
7 Jul 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award
Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )
14 Jun 2015

Applications of chimaeric antigen receptor T-cells in leukaemia

Dr Carl June - University of Pennsylvania, Philadelphia, USA
Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )
14 Jun 2015